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Purpose: Superoxide (O2.-) may function as a second messenger or regulator of signal transduction when produced at low
concentrations in the proper locations within cells. The purpose of these studies was to determine whether human corneal
stromal (HCS) fibroblasts are capable of producing O2.- via nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases, a family of protein complexes believed to be responsible for the localized and limited production of O2.- with
regulatory activity.
Methods: HCS cells, grown as primary and low-passage cultures of fibroblasts, were used as the sources of RNA for
reverse transcriptase PCR, with primers specific for mRNAs encoding the proteins that comprise NADPH oxidases. Small
interfering (si)RNAs were used to knockdown specific NOX mRNAs. Proteins composing the NADPH oxidase complexes
were identified using western blots. The production of O2.- by whole cells and cell-free preparations was assessed by
measurement of NADPH-dependent superoxide dismutase-inhibitable cytochrome c reduction.
Results: Whole cells and cell-free extracts of corneal stromal fibroblasts produced O2.- in an NADPH-dependent manner.
These  fibroblasts  constitutively  produced  mRNAs  encoding  eight  proteins  known  to  comprise  NADPH  oxidase
complexes. mRNAs encoding NOX1, NOX4, NOX5, p22 phox, p47 phox, p67 phox, and p40 phox as well as Rac were
expressed. Treatment of HCS fibroblasts with siRNA pools specific for each of these three NOXs significantly reduced
the steady state levels of the respective mRNAs. Western blots confirmed the existence of all the proteins required for
O2.- production. Rac 1, a regulator of the activity of some forms of NADPH complexes was present in membranous cell
fractions containing the oxidase proteins.
Conclusions: HCS fibroblasts produced O2.- in a NADPH-dependent manner via at least three isoforms of NADPH
oxidase. These cells expressed NOX1, NOX4, NOX5, p22 phox, p47 phox, p67 phox, and p40 phox as well as Rac. SiRNAs
directed against each of the three putative isoforms of NOX significantly reduced the steady state levels of the appropriate
NOX mRNA pools, thus confirming the existence of the three isoforms. The O2.- produced by the NADPH oxidases in
HCS fibroblasts is a potential contributor to signal transduction pathways and a regulator of gene expression as well as a
potential participant in processes that occur during inflammation.
Superoxide anion (O2
.-) is one of a group of molecules
referred to as reactive oxygen species (ROS). The production
of low amounts of O2
.- by nicotinamide adenine dinucleotide
phosphate  (NADPH)  oxidase  in  a  highly  regulated  and
localized manner can play critical roles in cell survival and
death [1-5]. O2
.- may be produced directly by enzyme activity
or  by  uncoupled  enzymes  (i.e.,  indirectly  by  enzymatic
reactions  where  the  reduction  of  molecular  oxygen  is  no
longer directly linked to product formation). Superoxide can
be produced in cells by several enzyme systems, including
xanthine oxidase, uncoupled nitric oxide synthase, complexes
I  or  III  of  the  mitochondrial  electron  transport  system,
uncoupled NADPH cytochrome P450 reductase, or NADPH
oxidases [6-9].
The NADPH oxidase family currently contains seven
members composed of multiple proteins that may exist in
several isoforms. The NADPH oxidase of neutrophils is the
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classic  membrane-bound  complex  that  is  assembled  upon
exposure of the cells to activating stimuli, such as bacterial
lipopolysacchride. The complex in neutrophils contains the
NOX2  protein  and  is  capable  of  the  production  of  large
amounts  of  O2
.-  [10].  This  oxidase  consists  of  NOX2
complexed with p22 phox, p47 phox , p67 phox, p40 phox,
and  Rac2.  The  complex  is  assembled  at  the  cytoplasmic
membrane  when  the  cell  receives  the  proper  stimulus.
NADPH  oxidase  complexes  are  also  responsible  for  the
production of O2
.- in several other cell types, including cardiac
myocytes, dermal epithelial cells, and kidney epithelial cells
[4,11,12].  Some  cells  contain  homologues  of  the  classic
NADPH oxidase proteins. The proteins of these homologous
complexes, as they exist in nonmyeloid cells, may contain any
of several isoforms of NOX, p47 phox, or p67 phox. Cells
containing  complexes  that  are  homologues  of  the  NOX2
oxidase produce relatively small amounts of O2
.- [13]. Cells
other than leukocytes and macrophages may express NOX
proteins (NOX1-5) as well as isoforms of p47 phox, p40 phox,
and p67 phox and Rac1 rather than Rac2 [14-16]. Several
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2535functions have been proposed for the O2
.- produced by these
NADPH complexes, including roles in apoptosis, senescence,
cell proliferation, oxygen sensing, signal transduction, and
regulation of hormone synthesis [1,4,17].
In the human cornea multiple potential sources of O2
.-
exist not only during inflammation but also in healthy tissue.
Enzymes,  such  as  xanthine  oxidase,  uncoupled  NADPH
cytochrome P450 reductase, nitric oxide synthase 2 (NOS2),
and complexes I and III of the mitochondrial electron transport
chain are all capable of O2
- production in corneal cells [8,
18-20].  Cells  derived  from  eyes,  including  rabbit  corneal
epithelial and stromal cells as well as human lens epithelial
cells and retinal vascular endothelial cells, contain modified
forms of NADPH oxidase complexes [20-23]. The expression
of NADPH oxidases has not been previously demonstrated in
human corneal stromal (HCS) cells, although O2
.- has been
hypothesized to contribute to keratoconus [24]. The results of
the studies reported here document that HCS cells are capable
of producing O2
.- by the oxidation of NADPH via NADPH
oxidases. The results demonstrate that the oxidases exist as an
NOX5 oxidase as well as NOX1 and NOX4 complexed with
p22 phox, p47 phox, p40 phox, p67 phox, or their homologues
and Rac.
METHODS
Cell culture: HCS cells were isolated, grown to confluence,
and subcultured, using modifications to published procedures
[25]. Corneal stromal cells were isolated from excised corneas
after removal of the epithelium and endothelium by scraping.
The stroma was digested for 16 h at 37 °C with 150 units/ml
collagenase (Clostridium histolyticium, Invitrogen, Carlsbad,
CA) in Hank’s balanced salts solution (HBSS) containing
penicillin G (100 units/ml) and streptomycin sulfate (100 μg/
ml; both from Sigma Aldrich, St. Louis, MO). The cells were
recovered by centrifugation (800× g), suspended in growth
medium, and grown at 34 °C in Dulbecco’s Modified Eagle
Medium (DMEM) containing 4.5 g/l glucose (Invitrogen), 5%
heat-inactivated defined fetal bovine serum (FBS; Hyclone/
Thermo  Scientific,  Waltham,  MA),  0.1%  Mito+serum
extender  (BD  Biosciences,  San  Jose,  CA),  and  10  μg/ml
ciprofloxacin (Sigma Aldrich). Cells were passaged at a 1:3
split ratio using 0.05% trypsin and 0.53 mM EDTA. Cells
were used in the first four passages.
Reverse transcriptase PCR and real-time PCR: Total RNA
was prepared using Trizol (Invitrogen) followed by DNA
digestion with DNase I (Invitrogen). Total RNA concentration
was determined by measuring the optical density at 260 nm.
cDNA  synthesis  was  performed  using  Superscript  III
(Invitrogen) and 1-2 μg of RNA. cDNA as amplified using
AmpliTaq Gold (Applied Biosystems, Foster City, CA) and
sequence-specific primers for standard reverse transcriptase
(RT)-PCR  (Table  1)  and  real-time  PCR  (Table  2).
Approximately 4-10% of the RT reaction mixture was used in
each PCR reaction containing 1-3 mM MgCl2, 200 µM each
deoxynucleotide  triphosphates  (dNTPs),  0.2  to  0.4  µM
primers, and 0.05 units/μl units AmpliTaq Gold in reaction
buffer (10 mM Tris-HCl, pH 8.3, and 50 mM KCl). The PCR
was run at 95 °C for 10 min then 40 cycles of 95 °C for 1 min,
54 to 62 °C for 1 min, and 72 °C for 1 min. Control reactions
were run in the absence of the RT in order to detect the
presence of amplifiable DNA that might be contaminating the
RNA preparation. The reaction products were detected on
ethidium  bromide-stained  NuSieve  (2%)  agarose  gels
(Cambrex Bioscience, East Rutherford, NJ).
Real-time quantitative amplifications were performed in
an ABI 7500 (Applied Biosystems), using SYBR Green PCR
Master Mix (Applied Biosystems) and 50-75 ng cDNA at 50
°C for 2 min, 95 °C for 10 min, 40 cycles of 95 °C for 15 s,
annealing for 1 min at 60 °C, then extension at 72 °C for 45
s. Primer concentrations for real-time PCR were 10 pM/20
μl.  Melt  curve  analysis  was  performed  by  an  additional
dissociation step of 1 cycle at 95 °C for 15 s and ramping data
collection at 60 °C for 1 min and 95 °C for 15 s. Data were
normalized  against  the  glyceraldehyde-3-phosphate
dehydrogenase  (GAPDH)  signal.  Primers  were  either
designed by us or as published by others (Table2) [26]. The
increase in fluorescence of SYBR Green was measured after
each extension step. CT values were calculated using ABI
software.  Relative  expression  values  were  obtained  by
normalizing CT values of the tested genes with CT values of
the housekeeping genes, using the ΔΔCT method.
Sequencing:  PCR  products  were  prepared  for  cycle
sequencing  by  gel  extraction  and  purification  with  the
QIAquick  Gel  Extraction  Kit  (QIAGEN,  Valencia,  CA).
Cycle sequencing of the purified DNA was carried out with
the ABI PRISM Big Dye Terminator v3.1 Cycle Sequencing
Kit (Applied BioSystems). The sequencing reactions were
processed  on  an  ABI  PRISM  3130xl  Genetic  Analyzer
(Applied BioSystems). The sequence analysis was done with
the  DNA  Sequencing  Analysis  Software,  Version  5.2
(Applied Biosystems) for Windows XP and Vista platforms.
Sequence alignments were done with the SeqMan II sequence
analysis software, version 5.06 (DNASTAR, Inc., Madison,
WI).
Western blot analysis: Cells were removed from cell culture
dishes in 15 mM HEPES buffer, pH 7.5, containing 145 mM
NaCl,  0.1  mM  MgCl2,  10  mM  ethylene  glycol  bis  (2-
aminoethylether) N, N, N, N1–tetraacetic acid (EGTA), 10
μg/ml  leupeptin,  10  μg/ml  aprotinin,  1  mM
phenylmethylsulfonylfluoride  (PMSF),  and  2  mM  sodium
orthovanadate (Na3VO4). Lysates were prepared by freeze
thawing, Dounce homogenization, and sonication twice, each
time for 15-s intervals at 100 W power. Cell debris was cleared
from the lysates by centrifugation at 200× g for 15 min at 4
°C.  Lysate  fractions  were  separated  into  soluble  and
particulate fractions by centrifugation at 29,000× g for 30 min
at 4 °C. The pellets were resuspended in modified RIPA buffer
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2536(50 mM Tris-HCl, pH 7.4, 1% Nonident P-40, 0.25% sodium
deoxycholate,  150  mM  sodium  chloride,  1  mM
ethylenediaminetetraacetic acid [EDTA], 1 mM PMSF, 5 μg/
ml aprotinin, 5 μg/ml leupeptin, 1 μg/ml pepstatin, 1 mM
Na3VO4,  and  1  mM  sodium  fluoride,  all  purchased  from
Sigma Aldrich). Protein concentrations were determined with
the  BCA  Protein  Assay  Reagent  Kit  (Pierce/Thermo
Scientific, Rockford, IL). Both the supernatant and particulate
fractions were stored at -80 °C.
Sodium  dodecyl  sulfate  polyacrylamide  gel
electrophoresis was performed on NuPAGE NOVEX Bis-
Tris–4-12% gels with MES SDS running buffer (50 mM Tris
base 2-(N-morpholino)ethanesulfonic acid), 1 mm EDTA,
0.1% sodium dodecyl sulfate pH 7.3; Invitrogen). Proteins
were  detected  on  the  immunoblots  with  the  SuperSignal
Femto  West  Chemiluminescent  Substrate  Kit  (Pierce),
according to the manufacturer’s directions. Development of
the blots was done with CL-XPosure Film (Pierce), using
Kodak GBX developer and fixer solutions (Pierce/Thermo
Scientific). Blots were reprobed after removing the antibodies
and substrates with the Restore Western Blot Stripping Buffer
(Pierce), according to the manufacturer’s directions.
Antibodies used in these studies included: gp91 phox
(611415) and p67 phox (69820; BD Biosciences); NOX5
TABLE 1. PRIMERS FOR THE DETECTION OF NADPH OXIDASE AND OTHER CDNAS IN HUMAN CORNEAL STROMAL FIBROBLASTS.
Primer name Sequence 5’→3’ Product (bp) Reference
HuNOX1-S1 GCCTGTGCCCGAGCGTCTGC 522 AJ438989
HuNOX1-AS2 ACCAATGCCGTGAATCCCTAAGC
HuNOX2-S1 GGAGTTTCAAGATGCGTGGAAACTA 549 [14]
HuNOX2-AS2 GCCAGACTCAGAGTTGGAGATGCT
HuNOX3-S1-2 CCATGGGACGGGTCGGATTGT 376 NM_015718
HuNOX3-AS2-2 GGGGGCAGAGGTAAGGGTGAAGG
HuNOX4-S1 GTCATAAGTCATCCCTCAGA 797 [45]
HuNOX4-AS2 TCAGCTGAAAGACTCTTTAT
NOX5-S1 ATCAAGCGGCCCCCTTTTTTCAC 238 [14]
NOX5-AS2 CTCATTGTCACACTCCTCGACAGC
P22PHOX-S1 GTTTGTGTGCCTGCTGGAGT 316 [46]
P22PHOX-AS2 TGGGCGGCTGCTTGATGGT
P47PHOXR-S1 CTCCCGCTGTCCACACCTGCTGAA 349 AF324409
P47PHOXR-AS2 GGGCTCTGGGTCCTCTGGCTCGTC
P67PHOX-S1 TACTTCCAACGAGGGATGCTC 714 [47]
P67PHOX-AS2 AGCTTTCCTCCTGGGCT
P67PHOXR-S1 CACGCCCGGATCTGCTTCAAC 363 AF323789
P67PHOXR-AS2 GTGGCGGGGCTCGACTTCAT
P40PHOXR-S1 TCATCTACCGCCGCTACCGCCAGTTC 473 AF323790
P40PHOXR-AS2 AGTGCCCTCCAGCCAGTCCTTGTTGA
P40PHOXR2-S1 CCGGAGGAAGATGACCCCACCAACTG 249 AF323790
P40PHOXR2-AS2 GCCTCGCCTGCCTCCACCAT
MuRAC1-S1 CCTACCCGCAGACAGTTGGAGACAC 395 XM_132485
MuRAC1-AS2 CTTGACAGGAGGGGGACAGAGAACC
MuRAC2-S1 GCCCCAGCACCCCCATCATCC 252 NM_009008
MuRAC2-AS2 AGGGGCGCTTCTGCTGTCGTGTG
MuRAC3-S1 GCTTCGGCCACTCTCCTATCCTCA 202 AB040819
MuRAC3-AS2 CTTCTTGTCCCGCAGCCGTTCA
MamGAPDH-S1 CCATGGAGAAGGCTGGGG 196 [48]
MamGAPDH-AS2 CAAAGTTGTCATGGATGACC
TABLE 2. REAL TIME PCR PRIMERS.
Primer name Sequence 5'→3' Product (bp) Reference
GAPDH-S1 CTCCTGCTCCTCTGTTCG 100 NM_002046
GAPDH-AS-1 TAGCTCCGACCTTCACCTTC
HuNOX1-S1 CACAAGAAAAATCCTTGGGTCAA 106 NM_013955
HuNOX1-AS1 GACAGCAGATTGCGACACACA
HuNOX4-S1 GCAGGAGAACCAGGAGATTG 125 NM_016931
HuNOX4-AS1 CACTGAGAAGTTGAGGGCATT
HuNOX5-S1 GCAGGAGAAGATGGGGAGAT 100 NM_024505
HuNOX5-AS1 CGGAGTCAAATAGGGCAAAG
p22phox-S1 CGCTGGCGTCCGCCTGATCCTCA 128 [26]
p22phox-AS1 ACGCACAGCCGCCAGTAGGTAGAT
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2537(SC-34707), NOX4 (SC-21860), MOX1/NOX1 (SC-5821),
p22 phox (SC-117212), p47 phox (SC-14015 and SC17845),
p67 phox (SC-7663), Rac1 (SC-217), and Rac2 (SC-96; Santa
Cruz Biotechnology, Santa Cruz, CA); p47 phox (05-540),
p40 phox (05-039), and Rac (05-389; Millipore, Bellerica,
MA) .
Assay  of  NADPH  oxidase  by  superoxide  dismutase-
inhibitable cytochrome c reduction: NADPH oxidase activity
was measured in a cell-free system in a manner similar to that
used by others [27]. Cells were grown to confluence, rinsed
in Delbeccos PBS without Ca+ or Mg++ (Gibco/Invitrogen,
Carlsbad,  CA),  and  harvested  with  trypsin  and  EDTA
treatment.  Trypsin  was  inhibited  with  Type  I-S  soybean
trypsin inhibitor (Sigma Aldrich), and the harvested cells were
washed with PBS at 4 °C and resuspended in buffer containing
20 mM 3-morpholino propane-1-sulfonic acid and potassium
hydroxide (MOPS–KOH buffer, pH 7.4), containing 250 mM
sucrose, 0.1 mM EDTA, 2 μM leupeptin, 1 μM aprotinin, and
2 μM pepstatin. The cells were disrupted after one freeze-thaw
cycle by two 20-s cycles of Dounce homogenization and two
15-s cycles of sonication at 100 W. Whole cells were removed
by centrifugation at 200× g for 5 min at 4 °C. The lysate was
fractionated by centrifugation at 29,000g for 15 min at 4 °C.
The pellet was then resuspended in 50 mM phosphate buffer
at pH 7.4 and stored at -80 °C. Paired assays were conducted
by incubation of 20-60 μg of protein with 10 mM phosphate
buffer, 130 mM NaCl, 1 mM EGTA, 10 μM flavin adenine
dinucleotide  (FAD),  2  mM  NaN3,  50  μM  oxidized
cytochrome c, and 10 μM guanosine 5' [γ-thio] triphosphate
(GTPγS). One reaction of each pair contained 200 units of
superoxide dismutase (SOD; Sigma Aldrich). Reactions were
initiated by the addition of NADPH to a final concentration
of 200 μM. After 1 h, activity was measured as the SOD-
inhibitable increase in absorbance at 550 nm (ΕmM=21). Assay
conditions  were  established  documenting  the  linearity  of
superoxide production with time and protein concentrations.
Superoxide production in whole cells: HCS fibroblasts were
grown to the fourth passage in DMEM without phenol red and
containing Mito+ and 5% FBS. Cells were harvested using
trypsin and EDTA and washed three times with HBSS without
Ca and Mg. Cells (107) were resuspended in PBS, pH 7.2,
containing 100 μg/ml bovine serum albumin and protease
inhibitor cocktail (EDTA free complete protease mix; Roche
Diagnostics,  Indianapolis,  IN).  Reduced  streptolysin  O  (5
units/ml; Sigma Aldrich) was added, and the mixture was
incubated for 10 min at 37 °C [28]. The permeabilized cells
were chilled to 4 °C, harvested by centrifugation, and washed
with  phosphate  buffer,  pH  7.2.  To  measure  superoxide
production  permeabilized  cells  (1×105  to  1×106)  were
resuspended in duplicate tubes, with and without 200 units of
SOD, containing 30 mM MOPS (pH 7.2), 100 μM FAD, and
100  μM  oxidized  cytochrome  c,  incubated  at  room
temperature  for  5  min,  and  NADPH  added  to  a  final
concentration of 200 μM. The change in optical density at 550
nm was recorded every 5 min for 1 h. At the conclusion of the
experiment,  cells  were  lysed  in  20  mM  HEPES  buffer
containing 1% Triton X-100, and the protein quantitated using
the BCA Protein Assay Reagent Kit. Superoxide production
was expressed as SOD-inhibitable cytochrome c reduction/
min/mg protein.
Small interfering RNA treatment of cells: NOX1, NOX4, and
NOX5 ON-Target Plus siRNA pools were purchased from
Dharmacon (Lafayette, CO). SiRNA complexes were formed
in  serum-free  medium,  using  INTERFERIN  (PolyPlus;
Genesee  Scientific,  San  Diego,  CA),  according  to  the
manufacturer’s  instructions.  Optimal  siRNA/INTERFERIN
concentrations were established. Cells were plated at 50-60%
confluence  in  DMEM  containing  5%  FBS,  Mito+serum
extender  (Gibco,  Carlsbad,  CA),  and  ciprofloxacin  and
maintained at 34 °C. Twelve to 16 h post plating, the media
was removed and the cells rinsed with HBSS. The cells were
treated with a final concentration of 40 nM siRNA. Cells were
transfected  with  complexes  in  media  composed  of
INTERFERIN  in  DMEM  containing  5%  FBS  Mito+  and
ciprofloxacin ( in a 1 to 50 ratio) for 16 h. The media was
removed  and  replaced  with  DMEM  with  5%  FBS  and
ciprofloxacin. After 96 h post transfection, the media was
removed, the cells were rinsed in PBS, and the RNA was
extracted  with  Trizol,  according  to  the  manufacturer’s
instructions. The amount of mRNA was determined by real-
time PCR, as described above.
Statistical  analysis:  Means  were  compared  by  one-way
analysis  of  variance,  and  the  significance  of  differences
among means of treatment groups was determined by the
Holm-Sidak method (Sigma Stat 3.0; SPSS Inc., Chicago, IL).
RESULTS
NADPH-dependent superoxide production by whole cells and
membranes:  Cultures  of  HCS  cells  were  grown  in  serum
containing  medium  as  fibroblasts.  Cells  were  harvested,
permeabilized, and O2
.- production was measured as SOD-
inhibitable  cytochrome  c  reduction.  Whole  cells
permeabilized  with  streptolysin  O  produced  O2
-  in  an
NADPH-dependent manner (Figure 1). Membranes prepared
from human stromal fibroblasts produced O2
.- at a rate of
4.24±0.03 nmole/min/mg protein (Figure 2). The addition of
inhibitors of nitric oxide synthase, L-NAME or 1400W, or an
inhibitor of xanthine oxidase, allopurinol, did not significantly
reduce the production of O2
.-, thus indicating that NADPH
oxidase was the source of the O2
.- . NADH did not serve as an
effective substrate so the source of the activity was likely not
the electron transport chain (Figure 2). The oxidase inhibitor,
diphenyliodonium  (DPI),  reduced  activity  by  90%,  thus
indicating that NADPH oxidase was the likely source of O2
.-
production (Figure 2).
Detection of transcripts of NADPH oxidase and proteins:
Cultures of human stromal fibroblasts expressed three NOX
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2538transcripts when grown in DMEM containing 5% FBS. PCR
reactions  containing  cDNAs  prepared  from  cultures  of
stromal cells produced the appropriate products from primers
for NOX1, NOX4, and NOX5 (Figure 3A-C). RT PCR using
NOX4  primers  amplified  a  region  of  the  NOX4  coding
sequence,  including  bp  1686  to  1855,  which  was  98.0%
identical to that originally discovered in cells from the kidney,
NM_016931.2 [14]. The NOX5 RT PCR product was 99.0%
identical to a region encoding a portion of the EF hand /Ca
binding region of the NOX5 from human testes NM_024505
[29]. Western blots using antibodies to NOX1, NOX4, and
NOX5 confirmed that these NOX proteins were expressed in
HCS fibroblasts (Figure 4A-C).
Cultured HCS fibroblasts also produced transcripts of
other proteins required to form functional NADPH complexes
with  NOX1  and  NOX4  (Figure  3).  HCS  fibroblasts  did
express mRNAs for p22 phox, p47 phox, p40 phox, and p67
phox,  as  detected  by  RT-PCR  reactions  using  sequence-
specific  primers  (Figure  3D-H).  HCS  fibroblasts  also
constitutively  expressed  Rac1,  as  amplified  with  Rac1-
specific primers (Figure 3H).
Western blots using antibodies to p22 phox did detect the
production of a protein of the correct molecular weight for p22
phox (Figure 4D). A single dominant band of protein at about
47 kDa was detected with antibodies to p47 phox (Figure 4E).
Western  blots  prepared  with  antibody  to  p40  phox  and
proteins extracted from HCS fibroblasts showed a band at 44
kDa when probed with the monoclonal antibody clone 1.9
(Millepore;  Figure  4F).  Blots  prepared  using  mouse
monoclonal antibody to p67 phox detected a dominant band
Figure 1. Nicotinamide adenine dinucleotide phosphate-dependent
superoxide production by human corneal stromal fibroblasts. Cells
were  grown  in  cell  culture,  harvested,  and  permeabilized  with
streptolysin O. The permeabilized cells (2.5×105) were incubated in
3-morpholinopropane-1-sulfonic  acid  (MOPS)  buffer  in  the
presence  and  absence  of  200  units  of  superoxide  dismutase  (as
described in the Methods). Reactions were initiated by the addition
of (●) 200 µM NADPH, (○) 200 µM NADH, or (▼) no substrate.
The superoxide dismutase-inhibitable change in optical density at
550 nm (OD550) is plotted verses time for 2.5×105 cells.
of  protein  at  65-67  kDa,  indicating  that  p67  phox  was
constitutively  produced  (Figure  4G).  Western  blots  using
antibodies  to  Rac  produced  a  21  kDa  band  in  membrane
containing fractions of HCS fibroblasts (Figure 4H). While
these data do not prove that Rac is bound to the complex of
NADPH oxidase proteins in the membrane, the data indicate
that  NOX1  and  other  oxidases  that  require  Rac  have  the
potential to be active.
Small  interfering  RNA  suppression  of  NADPH  oxidase
activity:  HCS  fibroblasts  were  treated  with  siRNAs  to
NOX1, NOX4, or NOX5 to confirm the existence of these
multiple forms of NOX. HCS fibroblasts were treated with
siRNA smart pools or nontarget control siRNAs, as described
in  the  Methods  section.  Real-time  PCR  documented
reductions  in  the  steady  state  mRNA  pools  by  67%  for
NOX1,  59%  for  NOX4,  and  73%  for  NOX5  at  96  h  post
treatment (Figure 5).
DISCUSSION
HCS  fibroblasts  produced  O2
.-,  as  detected  by  NADPH-
dependent,  SOD-inhibitable,  cytochrome  c  reduction.
Membranes prepared from these cells retained the ability to
produce O2
.- in a manner that was inhibitable by DPI but that
Figure  2.  Nicotinamide  adenine  dinucleotide  phosphate  oxidase
activity  in  membrane  preparations  of  human  corneal  stromal
fibroblasts  as  assayed  by  superoxide  dismutase-inhibitable
cytochrome c. Human corneal stromal fibroblasts were grown in cell
culture, harvested, lysed, and the membranous fraction harvested as
the 29,000× g pellet, as described in the Methods. Cell lysates were
assayed  for  superoxide  production  under  various  conditions:  (1)
NADPH as substrate, (2) NADPH as substrate in the presence of 100
μM L-NAME, (3) NADPH as substrate in the presence of 50 µM
1400W,  (4)  NADPH  as  substrate  in  the  presence  of  10  µM
diphenyliodonium, (5) NADPH as substrate in the presence of 100
µM allopurinol, and (6) NADH as substrate. Each bar represents the
mean  specific  activity  +/-  standard  deviation  (n=3).  An  asterisk
indicates  a  significant  reduction  in  SOD  inhibitable  superoxide
production, (p<0.001).
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2539was insensitive to L-NAME and allopurinol. NADPH was the
preferred substrate, while NADH was a poor substrate. These
observations indicate that the source of the O2
.- was not NOS,
xanthine  oxidase,  or  the  mitochondrial  electron  transport
chain.  The  rate  of  O2
.-  production,  the  dependence  upon
NADPH as the substrate, and the specific activity of O2
.-
production  were  indicative  that  NADPH  oxidase  was  the
source of O2
.-.
HCS fibroblasts expressed three NOX genes as well as
five genes whose products serve as accessory proteins that
compose  O2
.--producing  NADPH  complexes.  RT-PCR
products  generated  with  gene-specific  primers  and  the
proteins detected by western blots documented the expression
Figure 3. Reverse transcriptase PCR products of NADPH oxidase
related genes. HCS fibroblasts were grown to confluence and the
RNA extracted from cultures and amplified by RT PCR. Sequence
specific  primers  produced  the  appropriate  PCR  products  for  the
NADPH oxidase gene products and Rac including A: NOX1, B:
NOX4,  C:  NOX5,  D:  p22phox,  E:  p47phox,  F:  p40phox,  G:
p67phox, and H: Rac. Row 1: molecular weight standards. Row 2:
reverse  transcriptase.  (RT)  PCR  products  from  human  corneal
stromal fibroblasts; Row 3, no RT controls.
of  NADPH  oxidase  components.  SiRNA  knockdowns  of
mRNA pools confirm the expression of the NOX mRNAs.
NOX1,  NOX4,  and  NOX5  mRNAs  were  produced  in  a
constitutive  manner  at  detectable  levels  when  cells  were
grown  in  serum  containing  medium.  NOX2  mRNA  was
detected, but no protein was found despite the use of multiple
NOX2 antibodies along with positive and negative controls.
In addition, neither NOX3 mRNA nor protein was detected.
The literature now indicates that it is not unusual for a given
cell  type  to  express  multiple  NOXs  [4,30].  It  has  been
Figure 4. Western blots of proteins from human corneal stromal
fibroblasts. HCS fibroblasts were grown to confluence in DMEM
containing 5% FBS. The cell membranes were prepared and lysed in
RIPA.  The  aliquots  of  proteins  were  then  analyzed  by  western
blotting. The primary antibodies detected proteins of the correct
molecular weight; Row 1, Magic Mark molecular weight standards;
Row 2, empty; Row 3, positive control protein as detected protein as
detected in HL60, HEK or HUVEC cells; Row 4, proteins as detected
in HCS fibroblasts. Primary antibodies include A: NOX1, B: NOX4,
C: NOX5, D: p22 phox, E: p47 phox, F: p40 phox, G: p67 phox, and
H: Rac.
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2540hypothesized that each isoform of NOX may function in a
specific manner by virtue of its localized production of O2
.-
[1].  Future  studies  will  need  to  document  the  subcellular
localization and function of these NADPH oxidases in corneal
stromal cells.
Among  the  three  isoforms  of  NOX  present  in  HCS
fibroblasts,  NOX5  produces  O2
.-  in  a  strictly  NADPH-
dependent manner when bound to the cytoplasmic membrane
[31,32]. The accessory proteins are not required for activity
of NOX5 [33]. NOX5 has been reported to exist in any of five
isoforms (α, β, γ, δ, and ε) [34]. The literature indicates that
the molecular weight of NOX5 may range from 65 to 85 kDa,
depending  on  the  isoform  present  and  the  extent  of
glycosylation [31]. The NOX5 gene encodes a protein with a
molecular weight of 64.7 kDa, which is close to the estimated
molecular weight of the protein that we detect with the NOX5
antibody  [14].  The  fact  that  NOX5  siRNA  reduced  the
production  of  mRNA  indicates  that  NOX5  is  actively
expressed in HCS fibroblasts.
Unlike NOX5, NOX4 requires p22 phox for stabilization
and  activity  [5].  NOX4  does  not  require  other  accessory
proteins  for  activity  [4].  NOX4  appears  to  localize  in
membranes of cells, such as the cytoplasmic membrane and
endoplasmic reticulum, but its localization appears cell-type
dependent [35]. The data suggest that in some cells the activity
Figure  5.  Relative  mRNA  content  of  cells  treated  with  small
interfering RNAs to NOX1, NOX4, or NOX5. Human corneal stromal
fibroblasts were treated with 40 nM small intefering (si)RNAs to
nontarget controls (lanes 1,3, and 5) or NOX1-specific (lane 2),
NOX4-specific (lane 4), or NOX5-specific (lane 6) siRNAs. RNA
was extracted and amplified in triplicate amplification by real-time
reverse  transcriptase  PCR,  using  the  SYBR  Green.  Each  bar
represents the mean and standard error of the mean of triplicate
amplifications  of  RNAs  extracted  from  triplicate  cultures.  A
significant reduction (p<0.05) in the steady state level of RNA was
observed for each specific mRNA relative to cultures treated with
non-target control RNAs.
of NOX4 is Rac dependent [36]. NOX4 can be active when
complexed with p22 phox alone, but other studies indicate that
accessory proteins present in the cytoplasm can be activated
and complex with NOX4 and p22 phox to regulate NOX4
activity [33]. A variety of agents have been documented to
activate  NOX4,  including  lipopolysaccharides,  cytokines,
growth factors, angiotensin II, phorbol mynistic acid (PMA),
and insulin [4]. Each activating stimuli has been observed to
have  its  effects  in  a  cell-type  and  sometimes  species-
dependent fashion. NOX4 has a predicted molecular weight
of 66.9 kDa and is often detected as a protein of about 65 kDa
by western blots, as we have detected [14]. NOX4-targeted
siRNA treatment of HCS fibroblasts reduced the pools of
mRNA, confirming the existence of the NOX4 message.
The  NOX1  homologue  has  been  detected  in  a  wide
variety of cell types and tissues. NOX1 has been observed in
three isoforms, but the full-length gene encodes a protein in
the  range  of  55-60  kDa,  as  we  have  detected  in  HCS
fibroblasts [4]. The subcellular localization of NOX1 is not
well defined as it seems to vary in a cell-type-dependent
manner. O2
.- produced as a result of NOX1 activity has been
observed to enhance proliferation of some cell types while
inhibiting the growth of other cells [37,38]. Unlike NOX3 and
5, NOX1 gene expression and activity is regulated by growth
factors and cytokines [4]. NOX1 mRNA was detected, and a
NOX1  antibody-reactive  protein  of  about  65  kDa  was
detected in membrane fractions of HCS fibroblasts. NOX1
requires p22 phox and an organizer protein, like NOXO1 or
p47 phox, as well as a NOX activator protein like NOXA1 or
p67  phox,  and  Rac  for  efficient  O2
.-  production  [39].
Treatment  of  cells  with  NOX1  siRNA  suppressed  NOX1
mRNA accumulation, documenting the existence of NOX1
mRNA  pools  within  HCS  fibroblasts.  It  remains  to  be
determined  how  NOX1  activity  is  regulated  in  HCS
fibroblasts and what the biological activity is of the O2
.- it
produces.
HCS fibroblasts also expressed mRNAs encoding p22
phox, p47 phox, p67 phox, and Rac. These proteins are either
required  or  regulate  the  activities  of  NOX1,  2,  3,  and  4
oxidases  [13,33].  Each  of  these  proteins  has  specific
functions. P22 phox interacts with the NOX proteins and
becomes part of a membrane-bound electron transfer complex
know as cytochrome b558 [13]. HSC fibroblast constitutively
expressed  p22  phox  mRNA  and  western  blots  with  two
different antibodies, indicate that the protein was present in
the  cytosol  and  membrane  fractions.  A  second  accessory
protein required for NOX2 and NOX1 activity is p47 phox,
the organizer protein [33]. P47 phox binds to the p22 phox/
NOX  complex  via  the  Src  homology  domain  and  to
membranes by a PX domain [40,41]. It has been reported that
in some cells p47 phox can be replaced functionally by a p47
phox homologue, NOXO1 (NOX organizer1) [42]. Based on
the primers that we used and the antibodies available to us, it
is not clear that we could distinguish between p47phox and its
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2541homologue. It appears that HCS fibroblasts produce p47 phox.
A third protein that is known to activate the classic NOX2
complex and may modify the activity of NOX1, NOX3, and
NOX4  complexes  is  p67  phox.  A  p67  phox  homologue,
NOXA1  (NOX  activator)  contributes  to  the  activation  of
NOX1 in some cells [40]. P67 phox is expressed in HCS
fibroblasts.  A  fourth  protein  believed  to  contribute  to  the
activity of some NADPH oxidases is p40 phox. P40 clearly
influences the activity of NOX2 NADPH oxidases, but it has
not  been  clearly  established  to  what  extent  it  affects  the
activity of NOXs 1 and 3 [4]. P40 phox binds to p47 phox and
p67 phox in NOX1 and NOX2 NADPH oxidase complexes.
Our  data  clearly  demonstrated  its  expression  in  HCS
fibroblasts. While p40 phox is contained within membranous
fractions, it does not appear to be required for activity of
NOX1, based on the work of others [4]. Rac, another protein
that appears to be required for full activity of NOX1, 2, and 3
and which may influence the activity of NOX4 oxidases was
produced  and  was  bound  to  membrane  fractions  in  HCS
fibroblasts [39,43,44].
HCS fibroblasts produce O2
.- in a constitutive manner
consistent  with  NADPH  oxidase  activity.  mRNAs  and
proteins  required  to  form  functional  NOX1,  NOX4,  and
NOX5  NADPH  oxidases  were  detected  in  these  cells.
Membranous  fractions  prepared  from  HCS  fibroblasts
produced  O2
.-  in  an  NADPH-dependent  manner  that  was
consistent with NADPH oxidase activity. Both RT PCR and
western  blotting  indicate  that  the  accessory  proteins  p22
phox , p47 phox, p67 phox, p40 phox, and and Rac are all
expressed in HCS fibroblasts. Treatment of cells with siRNAs
for NOX1, NOX4, and NOX5 reduced the amount of each
respective mRNA in cells. NOX and accessory proteins were
present in membranous fractions prepared from cells, as we
have described. The functions of the O2
.- produced by each of
the NOX oxidases remain to be discovered.
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